{
    "clinical_study": {
        "@rank": "8040", 
        "acronym": "CAP-START", 
        "arm_group": [
            {
                "arm_group_label": "Betalactam monotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Preferred empirical treatment for patients in this arm is Beta-lactam monotherapy e.g. co-amoxiclav or ceftriaxone"
            }, 
            {
                "arm_group_label": "Betalactam combination with macrolide", 
                "arm_group_type": "Active Comparator", 
                "description": "Preferred empirical treatment for patients in this arm is beta-lactam combination therapy with a macrolide e.g. ceftriaxone and erythromycin"
            }, 
            {
                "arm_group_label": "Quinolone monotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "Preferred empirical treatment for patients in this arm is quinolone monotherapy e.g. moxifloxacin or levofloxacin"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the cost(effectiveness) of three existing antibiotic\n      strategies for patients with community-acquired pneumonia admitted to the hospital, but not\n      the ICU."
        }, 
        "brief_title": "Community-Acquired Pneumonia - Study on the Initial Treatment With Antibiotics of Lower Respiratory Tract Infections", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Actual"
        }, 
        "condition": "Community-acquired Pneumonia", 
        "condition_browse": {
            "mesh_term": [
                "Pneumonia", 
                "Respiratory Tract Infections"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  All patients admitted to one of the participating hospitals needing treatment for\n             CAP, not being admitted to the ICU are eligible for study inclusion.\n\n          -  Admission is defined as hospital stay for more than 24 hours.\n\n        Exclusion Criteria:\n\n          -  Patients who are readmitted with CAP within 2 weeks after a previous episode are not\n             eligible.\n\n          -  Patients with cystic fibrosis are not eligible."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "2283", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "May 2, 2012", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01660204", 
            "org_study_id": "10-148", 
            "secondary_id": "80-82310-97-12044"
        }, 
        "intervention": {
            "arm_group_label": [
                "Betalactam monotherapy", 
                "Betalactam combination with macrolide", 
                "Quinolone monotherapy"
            ], 
            "description": "The investigators are using a cluster-randomized cross-over design for preferred empirical treatment. One of the 3 treatment arms is used as preferred empirical therapy during a period of 4 consecutive months, after which preferred treatment will rotate to 1 of the other 2 regimens. The order of change is randomised per hospital, thereby controlling for inter-hospital variables and minimizing seasonal influences.", 
            "intervention_name": "Preferred empirical treatment", 
            "intervention_type": "Other"
        }, 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Beta-Lactams", 
                "Antibiotics, Antitubercular"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": "pneumonia, anti-bacterial agents, (cost)efficacy", 
        "lastchanged_date": "April 22, 2014", 
        "link": {
            "description": "Dutch website of study progress", 
            "url": "http://www.cap-studies.nl"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "Alkmaar", 
                        "country": "Netherlands"
                    }, 
                    "name": "Medical Center Alkmaar"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Amsterdam", 
                        "country": "Netherlands"
                    }, 
                    "name": "AMC Amsterdam"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Breda", 
                        "country": "Netherlands"
                    }, 
                    "name": "Amphia Hospital Breda"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Haarlem", 
                        "country": "Netherlands"
                    }, 
                    "name": "Kennemer Gasthuis"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Hoofddorp", 
                        "country": "Netherlands"
                    }, 
                    "name": "Spaarne Hospital"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands"
                    }, 
                    "name": "UMC Utrecht"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Utrecht", 
                        "country": "Netherlands"
                    }, 
                    "name": "Diakonessenhuis Utrecht"
                }
            }
        ], 
        "location_countries": {
            "country": "Netherlands"
        }, 
        "number_of_arms": "3", 
        "official_title": "Antibiotic Treatment of Community-acquired Pneumonia: a Prospective Comparison of Dutch Guideline Advices.", 
        "overall_official": {
            "affiliation": "UMC Utrecht", 
            "last_name": "Marc J. Bonten, MD PhD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Netherlands: Medical Ethics Review Committee (METC)", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "We will assess all-cause mortality on day 90 from admission from the municipal personal records database", 
            "measure": "Day 90 Mortality", 
            "safety_issue": "No", 
            "time_frame": "90 days from admission"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01660204"
        }, 
        "responsible_party": {
            "investigator_affiliation": "UMC Utrecht", 
            "investigator_full_name": "MJM Bonten", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "measure": "Length of intravenous antibiotic treatment", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 week"
            }, 
            {
                "measure": "Length of hospital stay", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 week"
            }, 
            {
                "description": "Side-effects and complications from antibiotic therapy are registered from clinical record", 
                "measure": "Tolerability", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 week"
            }, 
            {
                "description": "Complications of pneumonia during admission are registered from clinical record.", 
                "measure": "Complications", 
                "safety_issue": "No", 
                "time_frame": "Participants will be followed for the duration of hospital stay, an expected average of 1 week"
            }, 
            {
                "description": "Health care costs and non-health care costs are assessed using a short questionnaire 28 days from admission", 
                "measure": "Health care costs and non-health care costs", 
                "safety_issue": "No", 
                "time_frame": "28 days from admission"
            }
        ], 
        "source": "UMC Utrecht", 
        "sponsors": {
            "collaborator": {
                "agency": "ZonMw: The Netherlands Organisation for Health Research and Development", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "UMC Utrecht", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "February 2011", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}